WAM
MREO

Wealthspire Advisors (Maryland)’s Mereo BioPharma MREO Stock Holding History

Wealthspire Advisors (Maryland)’s Portfolio MREO Stock Details MREO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$37K Hold
14,276
– – ﹤0.01% 479
2020
Q2 		$44K Hold
14,276
– – ﹤0.01% 444
2020
Q1 		$15K Buy
+14,276
New +$24.7K ﹤0.01% 431

Other funds holding MREO

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Wealthspire Advisors (Maryland)'s MREO Position: Q3 2020 in Review

Wealthspire Advisors (Maryland) held its Mereo BioPharma (MREO) position steady in Q3 2020 at 14,276 shares worth $37K. The position accounts for ﹤0.01% of the portfolio, ranked #479.

Wealthspire Advisors (Maryland) first reported a position in MREO in Q1 2020 and has held it in 3 quarters since. The position peaked at $44K in Q2 2020. 28 funds tracked by Wall St. Rank hold MREO as of Q3 2020.

  • Wealthspire Advisors (Maryland) held 14,276 shares of Mereo BioPharma worth $37K as of Q3 2020.
  • Wealthspire Advisors (Maryland) left its Mereo BioPharma share count unchanged in Q3 2020.
  • Mereo BioPharma made up ﹤0.01% of Wealthspire Advisors (Maryland)'s portfolio in Q3 2020, its #479 holding.
  • Wealthspire Advisors (Maryland) first reported a position in Mereo BioPharma in Q1 2020 and has held it in 3 quarters since.
  • Wealthspire Advisors (Maryland)'s Mereo BioPharma position peaked at $44K in Q2 2020.
  • 28 funds tracked by Wall St. Rank held Mereo BioPharma as of Q3 2020.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q3 2020, filed 13 Nov 2020.